Pharvaris
Price & Volume
Stats
See more52W Range | $11.51-$26.33 |
Market Cap | $1.6B |
Shares Short | 404,968 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.65 |
News
See moreYahoo Finance • last month
Pharvaris stock price target lowered to $52 by Citizens JMP
Yahoo Finance • last month
Pharvaris NV (NASDAQ:PHVS) Reports Wider Q2 2025 Loss, Highlights Clinical Trial Progress
Yahoo Finance • 2 months ago
Pharvaris Announces Closing of $201.2 Million Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Yahoo Finance • 2 months ago
Pharvaris prices $175M securities offering
About
CEO | Mr. Berndt Axel Edvard Modig CPA, M.B.A. |
CFO | Mr. David W. Nassif J.D. |
Address | Grafenauweg 8, Zug, Switzerland, 6300 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 114 |
